Refine
Year of publication
- 2016 (3) (remove)
Document Type
- Doctoral Thesis (3)
Has Fulltext
- yes (3)
Is part of the Bibliography
- no (3)
Keywords
- Staphylococcus aureus (3) (remove)
Bacterial infections represent an increasing threat in human health and hospital- acquired infections meanwhile account for 99,000 deaths every year in the United States (Ventola, 2015). Live-threating bacterial infections will certainly emerge to an even more serious concern in future, essentially by accelerated development of antibiotic resistance. Only recently, the discovery of plasmid-encoded mcr-1, that confers resistance against colistin, marks the point where this highly transmissible resistance mechanism is now reported for every so far developed antibiotic (Liu et al., 2016). Staphylococcus aureus is a Gram-positive bacterium and well-known for its ability to quickly acquire resistance toward antibiotics either by chromosomal mutations and/or horizontal gene transfer (Pantosti et al., 2007). Although approximately 30% of the population is colonized with S. aureus (Kluytmans et al., 1997), it can transform to an invasive pathogen that causes a wide range of severe infections including pneumonia. The success of S. aureus as opportunistic pathogen can be attributed to combinations of several beneficial properties and capabilities including the expression of an arsenal of virulence factors (Archer, 1998), intracellular persistence (Garzoni & Kelley, 2009) and subversion of host cell defense mechanisms (Schnaith et al., 2007). The airway epithelium is the first line of defense against bacterial pathogens by forming a relative impermeable physical barrier composed of epithelial cells that are linked by tight junctions, desmosomes and adherence junctions (Davies & Garrod, 1997). Additionally, the airway epithelium mediates the detection of bacterial pathogens via toll-like receptors (TLRs) that recognize a variety of bacterial molecular patterns such as lipopolysaccharide (LPS), peptidoglycan and flaggelin (Sha et al., 2012). This interaction is transduced via protein phosphorylations into the cell in order to promote adaptation to the infection by initiation of the adaptive and innate immune defense. Although few insights where obtained of the signaling host responses towards staphylococcal infections (Agerer et al., 2003; 2005; Ellington et al., 2001), a comprehensive description of the host signaling network is largely missing. Thus, this dissertation thesis focuses on the decipherment of phosphorylation-mediated signaling responses towards S. aureus infections in non- professional and professional phagocytes by mass spectrometry-based phosphoproteomic techniques. The results of this thesis are summarized in the four chapters. Chapter I introduces to recent advances in the development of methodologies applied in the field of phosphoproteomics, including quantification strategies, peptide fractionation techniques and phosphopeptide enrichment methods applied for the system-wide characterization of protein phosphorylations by mass spectrometry. Additionally, publications reporting phosphorylation-based host signaling responses towards bacterial pathogens or their molecular patterns that applied mass spectrometry-based phosphoproteomics are discussed. In chapter II, the responses of the human bronchial epithelial cell lines 16HBE14o- and S9 following challenge with staphylococcal alpha- toxin at the level of proteome and phosphoproteome are summarized. General and cell type-specific signaling events are highlighted and evidences linking the activity of the epidermal growth factor receptor (EGFR) with differences in tolerance toward alpha-toxin are provided. Chapter III describes the modulation of the host signaling network of 16HBE14o- airway epithelial cells triggered by infection with S. aureus including temporal dissection of signaling events. Several protein kinases were identified as important signaling hubs mediating the host response. Targeted pharmaceutical inhibition of these kinases was probed and resulted in reduction of intracellular bacterial load. Chapter IV describes the rearrangement of the kinome by the differentiation of THP-1 monocytes to macrophage-like cells by application of quantitative kinomics. This approach identified the kinase MAP3K7 (TAK1) as key mediator of bacterial clearance, chemokine secretion and the differentiation process itself.
Staphylococcus (S.) aureus ist vor allem bekannt als einer der Haupterreger nosokomialer Infektionen weltweit. Die Mechanismen, mit denen S. aureus und das Immunsystem des Wirtes miteinander interagieren sind komplex und bis heute nicht vollständig verstanden. Ziel der vorliegenden Dissertation war es daher, bekannte Virulenzfaktoren von S. aureus und Proteine, deren Funktion für das Bakterium bisher unbekannt ist, hinsichtlich ihrer Immunogenität und ihrer Fähigkeit, Interaktionen mit Zellen und Plasmafaktoren des humanen Blutes einzugehen, zu charakterisieren. Die Entwicklung und Anwendung eines für den Organismus S. aureus spezifischen Proteinmikroarray war eines der Hauptziele dieser Arbeit, welches unter der Bezeichnung Staph-Toxin-Ag verwirklicht wurde. Der Array trug bis zu 62 S. aureus-Antigene und zeigte sich als geeignet zur Charakterisierung und Quantifizierung von Antikörperantworten in verschiedenen humanen und murinen Wirtsproben, wie Blutplasma und -serum sowie anderen extrazellulären Flüssigkeiten wie Nasensekret und Bauchwasser von gesunden und infizierten Probanden. Im ‚Protein-Interaktionsassay‘ wurde der Staph-Toxin-Ag dazu verwendet, Interaktionen von S. aureus-Proteinen zu humanen Blutplasmaproteinen zu identifizieren – Faktor H, Fibronektin, Fibrinogen, Plasminogen und Vitronektin. Der Staph-Toxin-Ag wurde in zwei unabhängigen globalen Studien angewendet, welche die S. aureus spezifischen Antikörperantworten von gesunden humanen Probanden untersuchten, darunter Träger und Nicht-Träger von S. aureus. In der ersten Studie wurden die IgG-Antworten in den Blutplasmen, in der zweiten Studie die Antikörperantworten der Klassen IgG und IgA, hier in den Nasensekreten der Probenaden charakterisiert. In beiden Studien wurde wie erwartet eine enorme Heterogenität der detektierten Antikörperantworten innerhalb der Kohorten beobachtet, die unabhängig vom Trägerstatus bestand. Vergleichende Analysen der IgA- mit den IgG-Antworten in den Nasensekreten konnten den Grad der Heterogenität noch einmal deutlich erhöhen. Für keinen der untersuchten Probanden stimmten die S. aureus-Antigen-Muster beider Antikörperklassen vollständig überein. Für die untersuchten S. aureus-Träger wurden im Durchschnitt höhere Antikörperlevel nachgewiesen als für die Nicht-Träger. Statistische Analysen (Mann-Whitney U-Test) der gemessenen IgG- bzw. IgA-Level identifizierten insgesamt zehn Antigene, gegen die die Testgruppe der Träger im Vergleich signifikant höhere Antworten zeigte. Für das virulenzassoziierte Protein IsaA (Immunodominant staphylococcal Antigen A) wurden die beschriebenen Unterschiede in beiden globalen Studien und für beide untersuchten Antikörperklassen identifiziert. Die stärksten und häufigsten Antikörperantworten konnten gegen Proteine aus zwei funktionellen Gruppen – die nicht-egc-Superantigene (SEB, SEC, TSST-1) und die Komplement- und Koagulationsinhibitoren (SCIN, Efb, Sbi, SSL-7, SACOL1169) – detektiert werden. Mindestens 60 % der untersuchten Probanden zeigten spezifische IgG- und/oder IgA-Antworten gegen Komplementinhibitoren. Hingegen konnten für Superantigene vor allem Antikörperspezifitäten der Klasse IgG detektiert werden. Für den Komplementinhibitor Sbi (S. aureus Binder of IgG) wurde eine Lücke in den IgG-Antworten beobachtet. Beide funktionelle Gruppen werden folglich bei der Invasion des Wirtes von S. aureus in vivo exprimiert. Komplementinhibitoren sind darüber hinaus offensichtlich für S. aureus von besonderer Relevanz bei der Kolonisierung der Naseschleimhaut. Zahlreiche neue Erkenntnisse konnten gewonnen werden zu Proteinen, die von S. aureus sekretiert werden, deren Funktion für das Bakterium jedoch bisher unbekannt ist. Gegen zehn dieser Proteine wurden mithilfe des Staph-Toxin-Ag spezifische IgG- und/oder IgA-Antworten nachgewiesen, besonders häufig gegen die Antigene SACOL0479, SACOL0480, SACOL0985 und SaurJH1_2034. Dies zeigte, dass diese Proteine durch S. aureus in vivo synthetisiert werden und dass sie immunogen wirken. Im ‚Protein-Interaktionsassay‘ konnten für 20 der sekretierten Proteine mit unbekannter Funktion Interaktionen mit humanen Blutplasmafaktoren nachgewiesen werden. In durchflusszytometrischen Analysen mit humanem Vollblut wurden für sieben Proteine – SACOL0021, SACOL0742, SACOL0908, SACOL0985, SACOL1788, SACOL1802 und SACOL2197 – spezifische Bindungen an PMNs (Polymorphonuclear Leukocytes) und/oder Monozyten gezeigt. In der vorliegenden Dissertation wurden mithilfe immunologischer und durchflusszytometrischer Methoden potentielle neue Virulenzfaktoren, Vakzinkandiaten sowie diagnostische Biomarker identifiziert. Neben der wissenschaftlichen Anwendung ist der Proteinarray Staph-Toxin-Ag durch seine Eigenschaften prädestiniert für einen Einsatz als Screening-Methode in der diagnostischen Medizin.
Staphylococcus aureus is present in around a third of the human population as a constant commensal in the anterior nares, in a third as an intermittent commensal, and a third are non-carriers. However, S. aureus is also a dangerous pathogen, responsible for many types of infections. Recently, the emerging of methicillin-resistant S. aureus strains has aggravated the health problem. Treating infections caused by the invasive strains has become ineffective with conventional antibiotics. Noticeably, transmission of S. aureus has occurred not only in healthcare settings but also in the community; furthermore, transmission between humans and domestic animals has been reported. Although studies about host-pathogen interactions of S. aureus have advanced our knowledge in the last decades, we still have not fully understood mechanisms of the immune system in responses to S. aureus. The aim of this study is to unravel interactions of the human adaptive immune system to selected S. aureus virulence factors. In particular, the study focuses on two aspects: the reaction of human antibodies to the bacterial extracellular proteins in S. aureus-induced furunculosis with an emphasis on Panton-Valentine Leukocidin and responses of the adaptive immune system to membrane-bound lipoproteins of S. aureus. Furunculosis is a variety of hair follicle infection in which S. aureus is one of the chief causal pathogens involved. The corresponding bacterial strains are generally capable of producing of a pore-forming toxin, known as Panton-Valentine Leukocidin (PVL). Recently, the emerging of pvl-positive methicillin-resistant S. aureus has become a problem for treating the bacterially caused furuncles. Colonization with the bacteria is a risk factor for development of chronic or recurrent boils. It is not yet known why furunculosis patients are largely infants or young adults. In this context, we untangled the responses of antibody IgG antibodies to S. aureus extra-cellular factors, notably the PVL toxin, in families in which the patients were children. Multiplex PCR demonstrated that S. aureus clones, isolated from the patients’ wounds but also from the nares of family members, harbored genes coding for PVL toxin. Spa-typing highlighted that bacterial genotypes were very similar in each family. This suggests that transmission of pvl-positive S. aureus took place between family members. The finding also raises the question why only the young patients but not family members who were colonized by the same S. aureus clones suffered from furunculosis. 2D immune proteomics procedures showed a tendency of higher IgG titers against bacterial virulence factors in family healthy members than in patients. PVL-specific antibodies were measured using ELISA, in which patients’ PVL-specific IgG titers were low. This supports the idea that antibodies, probably in conjunction with T cells, might contribute to clinical protection in furunculosis. This research will serve as a foundation for future studies, in which our results should be validated in a larger cohort. Among S. aureus’ virulence factors are lipoproteins, which are anchored in the bacterial cell membrane. Lipoproteins perform various functions in colonization, immune evasion, and immunomodulation. These proteins are potent activators of the complex of innate immune receptors termed Toll-like receptors (TLR) 2 and 6. This study addressed the specific B-cell and T-cell responses to lipoproteins in human S. aureus carriers and non-carriers. 2D immune proteomics and ELISA approaches revealed that titers of serum antibody (IgG) binding to the S. aureus lipoproteins were very low or even unmeasurable in healthy individuals except for the lipoprotein SaeP. Only patients with cystic fibrosis or epidermolysis bullosa who were heavily exposed to the bacteria, generated an antibody response also to lipoproteins. Proliferation assays and cytokine profiling data showed only subtle responses of T cells in healthy individuals; three out of eight tested lipoproteins did not elicit proliferation. Hence, the robust activation of the innate immune system by S. aureus lipoproteins does not translate into a strong adaptive immune response. Reasons for this may be inaccessibility of lipoproteins for B cells as well as ineffective processing and presentation of the antigens to T cells. The main findings implicate that family members can serve as S. aureus reservoirs causing recurrent furunculosis in young patients and that antibodies may provide partial protection from such infections by S. aureus. We have found that, different from proteins that are secreted by S. aureus, lipoproteins which anchored in the bacterial cell membrane, do not trigger strong responses from the human adaptive immune system. This suggests that these proteins remain mostly hidden in the bacterial cell-wall.